Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 25, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 7N8Q | 7N8Q | Rhesusized RV305 DH677.3 Fab bound to Clade A/E 93TH057 HIV-1 gp120 core. | |
| 7N8I | 7N8I | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20) | |
| 7N8H | 7N8H | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement | |
| 7N65 | 7N65 | Complex structure of HIV superinfection Fab QA013.2 and BG505.SOSIP.664 | |
| 7N64 | 7N64 | SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction) | |
| 7N62 | 7N62 | SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction) | |
| 7N5H | 7N5H | Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
| 7N4M | 7N4M | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2151. | |
| 7N4J | 7N4J | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2173. | |
| 7N4I | 7N4I | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2057. | |
| 7N3T | 7N3T | TrkA ECD complex with designed miniprotein ligand | |
| 7N3I | 7N3I | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment C098 | |
| 7N2S | 7N2S | AS3.1-PRPF3-HLA*B27 | |
| 7N2R | 7N2R | AS4.3-PRPF3-HLA*B27 | |
| 7N2Q | 7N2Q | AS4.3-YEIH-HLA*B27 | |
| 7N2P | 7N2P | AS4.3-RNASEH2b-HLA*B27 | |
| 7N2O | 7N2O | AS4.2-YEIH-HLA*B27 | |
| 7N2N | 7N2N | TCR-antigen complex AS4.2-PRPF3-HLA*B27 | |
| 7N28 | 7N28 | Cryo-EM structure of broadly neutralizing V2-apex-targeting antibody J033 in complex with HIV-1 Env | |
| 7N19 | 7N19 | DR3 in complex with Aspergillus nidulans NAD-dependent histone deacetylase hst4 peptide | |
| 7N0U | 7N0U | Complex of recombinant Bet v 1 with Fab fragment of REGN5713 | |
| 7N0H | 7N0H | CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45) | |
| 7N0G | 7N0G | CryoEm structure of SARS-CoV-2 spike protein (S-6P, 1-up) in complex with sybodies (Sb45) | |
| 7N0A | 7N0A | Structure of Human Leukaemia Inhibitory Factor with Fab MSC1 | |
| 7N04 | 7N04 | Crystal structure of the apo F240 antibody fragment | |
| 7MZN | 7MZN | SARS-CoV-2 receptor binding domain bound to Fab PDI 231 | |
| 7MZM | 7MZM | SARS-CoV-2 receptor binding domain bound to Fab PDI 215 | |
| 7MZL | 7MZL | SARS-CoV-2 receptor binding domain bound to Fab PDI 210 | |
| 7MZK | 7MZK | SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 96 | |
| 7MZJ | 7MZJ | SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 93 | |
| 7MZI | 7MZI | SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 | |
| 7MZH | 7MZH | SARS-CoV-2 receptor binding domain bound to Fab WCSL 119 | |
| 7MZG | 7MZG | SARS-CoV-2 receptor binding domain bound to Fab PDI 42 | |
| 7MZF | 7MZF | SARS-CoV-2 receptor binding domain bound to Fab PDI 37 | |
| 7MYZ | 7MYZ | Structure of the full length 5-TM receptor CD47 bound to Fab B6H12 | |
| 7MY3 | 7MY3 | CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike | |
| 7MY2 | 7MY2 | CryoEM structure of neutralizing nanobody Nb30 in complex with SARS-CoV2 spike | |
| 7MXP | 7MXP | Cryo-EM structure of NTD-directed neutralizing antibody LP5 Fab in complex with SARS-CoV-2 S2P spike | |
| 7MXI | 7MXI | IgE-Fc in complex with DARPins E2_79 and E3_53 | |
| 7MXE | 7MXE | Ab1245 Fab in complex with BG505 SOSIP.664 and 8ANC195 Fab | |
| 7MXD | 7MXD | Cryo-EM structure of broadly neutralizing V2-apex-targeting antibody J038 in complex with HIV-1 Env | |
| 7MWX | 7MWX | Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2 with tamarin CD81 | |
| 7MWW | 7MWW | Structure of hepatitis C virus envelope full-length glycoprotein 2 (eE2) from J6 genotype | |
| 7MW6 | 7MW6 | Structure of the SARS-CoV-2 Spike trimer with three RBDs up in complex with the Fab fragment of human neutralizing antibody clone 2 | |
| 7MW5 | 7MW5 | Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 2 | |
| 7MW4 | 7MW4 | Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 6 | |
| 7MW3 | 7MW3 | Structure of the SARS-CoV-2 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6 | |
| 7MW2 | 7MW2 | Structure of the SARS-CoV-2 Spike trimer with all RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6 | |
| 7MSQ | 7MSQ | Complex between the Fab arm of AB-3467 and the SARS-CoV-2 receptor binding domain (RBD) | |
| 7MRZ | 7MRZ | Structure of GDF11 bound to fused ActRIIB-ECD and Alk4-ECD with Anti-ActRIIB Fab fragment |
